Table 1 Overall characteristics of the studies.
Characteristic | N (total = 54) | % |
|---|---|---|
Publication year | ||
2023–2024 | 4 | 7.41 |
2018–2022 | 18 | 33.33 |
2013–2017 | 6 | 11.11 |
2008–2012 | 10 | 18.52 |
2003–2007 | 4 | 7.41 |
1998–2002 | 7 | 12.96 |
1993–1997 | 5 | 9.26 |
Study region | ||
Africa | 4 | 7.41 |
Asia | 17 | 31.48 |
Australia | 1 | 1.85 |
Europe | 11 | 20.37 |
North America | 9 | 16.67 |
South America | 3 | 5.55 |
Europe and North America | 3 | 5.55 |
Worldwide* | 6 | 11.11 |
Antibiotic susceptibility testing method | ||
Broth dilution | 28 | 51.85 |
Disk diffusion | 11 | 20.37 |
Broth dilution and disk diffusion | 2 | 3.70 |
Not reported | 3 | 5.55 |
Other | 10 | 18.52 |
Sample size | ||
≤ 100 | 37 | 68.52 |
> 100 | 17 | 31.48 |
Study design | ||
Retrospective study | 32 | 59.26 |
Cross-sectional study | 19 | 35.19 |
Cohort study | 1 | 1.85 |
Prospective cohort study | 1 | 1.85 |
Surveillance study | 1 | 1.85 |
